Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136312 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chiara Brullo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy. Hauptthemen laut MEDLINE: Melanoma, Keratinocytes, Pyrazoles, Triazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To further extend the structure–activity relationships on previously identified anti-proliferative imidazo-pyrazoles, a novel series of compounds was designed and synthesized. In the obtained derivatives (1), the imidazo-pyrazole scaffold was formally condensed with a substituted triazole moiety, known for its biological properties. All derivatives were tested for anti-proliferative activity on a panel of 60 different cancer cell lines and compound 1h was identified as the most promising derivative, being highly effective against melanoma cells. Additional investigations demonstrated a cytotoxic and pro-oxidant action of the compound 1h on human metastatic melanoma cell lines (MeOV and MeTA) but not on healthy keratinocytes (HaCAT), confirming the selective activity of the compound. In silico calculations predicted favorable drug-like and pharmacokinetic properties and pre-formulation studies evaluated the effect of Tween 80 on 1h solubility. Overall, the collected data confirmed the pharmacological potential of the imidazo-pyrazole scaffold and indicated 1h as an interesting lead structure for the development of novel anti-melanoma agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.
- Department of Experimental Medicine (DIMES), University of Genova, Via Leon Battista Alberti 2, 16132 Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.
- Centro 3R, Department of Information Engineering, University of Pisa, Largo Lucio Lazzarino 1, 56122 Pisa, Italy.
- Department of Experimental Medicines, University of Genoa, Viale Benedetto XV 1, 16132 Genoa, Italy.
ORCID-Profile: Chiara Brullo, Barbara Marengo, Cinzia Domenicotti, Matteo Lusardi, Annalisa Salis, Eleonora Russo, Andrea Spallarossa
Zitieren
APA
Brullo, C., Marengo, B., Domenicotti, C., Lusardi, M., Cichero, E., Salis, A., Caviglia, D., Russo, E., & Spallarossa, A. (2025). Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136312
Vancouver
Brullo C, Marengo B, Domenicotti C, Lusardi M, Cichero E, Salis A, et al. Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136312
BibTeX
@article{Brullo2025,
author = {Brullo, Chiara and Marengo, Barbara and Domenicotti, Cinzia and Lusardi, Matteo and Cichero, Elena and Salis, Annalisa and Caviglia, Debora and Russo, Eleonora and Spallarossa, Andrea},
title = {Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136312}
}
EUVIMED